Crescentis Capital FY26 loss narrows to ₹25.26m

Key takeaways from the latest release

Crescentis Capital Limited reported a narrower net loss for the financial year ended March 31, 2026 (FY26), compared with the previous year. The company disclosed that its FY26 net loss stood at ₹25.263 million, improving from a loss of ₹54.224 million in FY25. Revenue from operations turned positive in FY26 at ₹14.838 million, compared with negative revenue of ₹30.248 million in FY25. Total income for FY26 was reported at ₹15.460 million. Alongside the annual update, quarterly numbers showed a sharp reversal in the March 2026 quarter, with negative revenue and a net loss. Investors tracking the stock also saw a marginal price move, with the displayed quote at ₹124.80, up ₹0.10 (0.08%).

FY26 results: narrower loss and improved EPS

For FY26, Crescentis Capital’s basic and diluted EPS was reported as a loss of ₹1.57, improving from a loss of ₹4.48 in FY25. The improvement in EPS aligns with the narrower net loss reported for the year. The company also reported that total revenue from operations reached ₹148.38 lakh in FY26, while FY25 had negative revenue of ₹302.48 lakh. Total income for the year stood at ₹154.60 lakh. These figures indicate a year-on-year improvement in the reported income line, even though the company remained in loss. The disclosure positions FY26 as a year of recovery in reported operating revenue compared to FY25.

March 2026 quarter: revenue and profit swung negative

The latest quarter (period ending March 2026) reflected a sharp deterioration on a sequential basis. Crescentis Capital reported sales (revenue) of -₹73.82 million for the quarter and a net income of -₹73.51 million, with EPS of -4.56. The company’s revenue moved from ₹37.20 million in the previous quarter to -₹73.82 million in the latest quarter. Net income also shifted from ₹11.93 million to -₹73.51 million compared with the prior quarter. In a quarterly table referenced alongside the results, total revenue for the March 2026 quarter was shown as -₹73.8 million versus ₹37.2 million in December 2025 and ₹0.7 million in March 2025. The same table showed net profit of -₹73.5 million for March 2026 versus ₹11.9 million in December 2025 and -₹37.8 million in March 2025.

What stood out: unrealised loss on equity investments

A notable line item disclosed for the year ended March 31, 2026 was an unrealised loss linked to the company’s equity investments. Crescentis Capital recognised an unrealised loss of ₹48.547 million due to adverse movements in market prices of its equity investments. This disclosure provides context for the reported profitability trend for the year, particularly for a company where investment valuation changes can materially influence reported earnings. The unrealised loss figure is specifically attributed to market price movements of equity holdings. Such accounting recognition can affect annual results even when cash flows are not immediately realised.

Profitability metrics and trailing EPS snapshot

The company’s EPS (TTM) was shown as -1.57. The same data set also displayed a negative P/E ratio of -76.75, reflecting negative earnings over the relevant period. Dividend yield was listed at 0.00%. EBITDA was shown as -₹28.87 million. These indicators are consistent with a business that has reported losses, while still being actively tracked through standard market valuation metrics. The latest quarter’s revenue per share was shown as 95.28.

Board and management: re-appointments approved

Crescentis Capital’s board approved the re-appointment of Mr. Subba Rao Veera Venkata Meka as Managing Director and Mr. Bhavanam Ruthvik Reddy as Whole-Time Director and CEO. The approved term is five years starting September 12, 2026. The disclosure signals continuity at the top management level following the FY26 reporting period. The appointments were referenced as board-approved re-appointments rather than new hires. The effective start date and tenure were explicitly stated.

Market view: stock quote and immediate context

The stock quote displayed alongside the financial snapshot showed ₹124.80, up ₹0.10 (0.08%). The dataset also included a separate end-of-day reference showing 135.00 on 18-02-2026 with a change of 10.20 (8.17%). These price points indicate the stock’s trading context around different dates shown in the material. However, the reported financial results themselves focus on the period ending March 31, 2026 and the latest quarterly release dated May 29, 2026.

Summary table: annual and quarterly numbers at a glance

Why the numbers matter for investors

The FY26 results show a clear year-on-year improvement in net loss and EPS, alongside a shift to positive revenue from operations compared with FY25’s negative operating revenue. At the same time, the March 2026 quarter highlights how quickly reported revenue and profit can swing, particularly when investment-related income and fair value movements influence the income statement. The disclosed unrealised loss due to market price movements of equity investments adds an important layer to interpreting FY26 profitability. For investors, separating annual improvements from quarterly volatility becomes essential when reviewing the latest filings and tables. The negative trailing indicators, including the negative P/E and negative EBITDA, reinforce that profitability remains a key monitorable.

Conclusion

Crescentis Capital’s FY26 update showed a narrower annual loss and improved EPS, while the March 2026 quarter recorded negative revenue and a sizeable net loss. The company also flagged an unrealised loss on equity investments and confirmed board-approved re-appointments of key executives effective September 12, 2026.